IMN || News

Use of nonregulated menopausal hormone treatment on the rise

Posted on: 07/03/2015 - 16:33

SAN DIEGO – An estimated 26-33 million prescriptions for compounded, non–FDA-approved menopausal hormone therapy are filled in the United States e... More »

Field of Interest: Pulmonology

Type: News Item

Acute anterior uveitis? Consider axial spondyloarthritis

Posted on: 06/03/2015 - 16:09

SNOWMASS, COLO. – Ankylosing spondylitis, far and away, is the most common systemic disease in North America associated with uveitis, Dr. James T. R... More »

Field of Interest: Rheumatology

Type: News Item

Burden of adult eczema includes drug costs, physician access, lost workdays

Posted on: 04/03/2015 - 18:15

U.S. adults with eczema reported significantly more out-of-pocket health care costs, lost workdays, and comorbid conditions than did their peers witho... More »

Field of Interest: Dermatology

Type: News Item

Cancer society critical of new chemo payment bundle

Posted on: 04/03/2015 - 16:21

A finalized Medicare payment model for chemotherapy is not much of an improvement from its draft version, according to the American Society of Clinica... More »

Field of Interest: Oncology

Type: News Item

ACP guidelines for preventing, treating pressure ulcers

Posted on: 02/03/2015 - 22:00

Alternating-air and low-air-loss mattresses and overlays have little data to support their use for preventing or treating pressure ulcers, the Clinica... More »

Field of Interest: Geriatrics

Type: News Item

ACP guidelines for preventing, treating pressure ulcers

Posted on: 02/03/2015 - 22:00

Alternating-air and low-air-loss mattresses and overlays have little data to support their use for preventing or treating pressure ulcers, the Clinica... More »

Field of Interest: Dermatology

Type: News Item

Bladder cancer ‘no longer one single disease’

Posted on: 02/03/2015 - 20:36

ORLANDO – Gene expression profiling can identify intrinsic bladder cancer subtypes, predict the clinical response to neoadjuvant chemotherapy, and s... More »

Field of Interest: Oncology

Type: News Item

Infliximab most common cause of drug-induced liver injury

Posted on: 01/03/2015 - 17:01

Infliximab caused liver injury in 8.3% of treated patients in a prospective study, exceeding rates for other tumor necrosis factor-alpha antagonists, ... More »

Field of Interest: Rheumatology

Type: News Item

Infliximab most common cause of drug-induced liver injury

Posted on: 01/03/2015 - 17:01

Infliximab caused liver injury in 8.3% of treated patients in a prospective study, exceeding rates for other tumor necrosis factor-alpha antagonists, ... More »

Field of Interest: Dermatology

Type: News Item

Infliximab most common cause of drug-induced liver injury

Posted on: 01/03/2015 - 17:01

Infliximab caused liver injury in 8.3% of treated patients in a prospective study, exceeding rates for other tumor necrosis factor-alpha antagonists, ... More »

Field of Interest: Gastroentero...

Type: News Item

« first
‹ previous
…
24
25
26
27
28
29
30
31
32
…
next ›
last »

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters